Intensity Therapeutics, Inc.
INTSNasdaqCIK 1567264HealthcareFiscal year ends Dec 31
Reports and events: 83 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-0916:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001567264-24-000011 |
| 2024-05-0916:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001567264-24-000010 |
| 2024-04-1916:01 ET | 8-K | 3.01 Delisting notice | 0001567264-24-000003 |
| 2024-03-1416:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-011219 |
| 2024-03-1416:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-011207 |
| 2024-02-0716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-011098 |
| 2023-12-1208:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-23-094884 |
| 2023-11-2216:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-23-089612 |
| 2023-11-1312:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-085791 |
| 2023-11-1308:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-085558 |
| 2023-09-0508:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-073586 |
| 2023-08-1417:25 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-06-30 | 0001213900-23-067270 |
| 2023-08-1412:45 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-066740 |
| 2023-08-1407:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-066456 |
| 2023-07-1008:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-055658 |
| 2023-07-0516:47 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-054818 |
| 2023-06-2910:51 ET | S-1/A | Registration statement, amended | 0001213900-23-052684 |
| 2023-06-2309:43 ET | S-1/A | Registration statement, amended | 0001213900-23-051151 |
| 2023-06-0915:20 ET | S-1/A | Registration statement, amended | 0001213900-23-047788 |
| 2023-05-1814:48 ET | S-1/A | Registration statement, amended | 0001213900-23-041113 |
| 2023-01-2716:16 ET | S-1/A | Registration statement, amended | 0001213900-23-005668 |
| 2023-01-1314:46 ET | S-1/A | Registration statement, amended | 0001213900-23-002717 |
| 2022-11-0209:40 ET | S-1/A | Registration statement, amended | 0001213900-22-068432 |
| 2022-10-0311:50 ET | S-1/A | Registration statement, amended | 0001213900-22-061060 |
| 2022-09-2020:16 ET | S-1/A | Registration statement, amended | 0001213900-22-057124 |
| 2022-05-1616:21 ET | S-1/A | Registration statement, amended | 0001213900-22-027136 |
| 2022-04-2019:29 ET | S-1/A | Registration statement, amended | 0001213900-22-020664 |
| 2022-01-0715:44 ET | S-1/A | Registration statement, amended | 0001213900-22-001099 |
| 2021-12-0913:28 ET | S-1/A | Registration statement, amended | 0001213900-21-064375 |
| 2021-12-0814:40 ET | S-1/A | Registration statement, amended | 0001213900-21-064145 |
| 2021-11-1817:21 ET | S-1/A | Registration statement, amended | 0001213900-21-060634 |
| 2021-11-1217:31 ET | S-1/A | Registration statement, amended | 0001213900-21-058814 |
| 2021-10-2817:15 ET | S-1 | Registration statement | 0001213900-21-055138 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.